ARID1A基因突变的临床试验
总计1847个结果
-
Ohio State University Comprehensive Cancer Center完全的
-
Istituto Scientifico Romagnolo per lo Studio e...未知
-
Sichuan Cancer Hospital and Research Institute尚未招聘
-
Second Affiliated Hospital of Nanchang UniversityNanchang University未知
-
Ullevaal University HospitalUniversity of Oslo未知
-
University Hospital, MontpellierHôpital Cochin; Hôpital Necker-Enfants Malades; Foch Hospital, Suresnes, FRANCE招聘中
-
Li Zhang, MD尚未招聘非小细胞癌 | 表皮生长因子受体基因突变中国
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人转移性结直肠腺癌 | IV 期结直肠癌 AJCC v8 | IVA 期结直肠癌 AJCC v8 | IVB 期结直肠癌 AJCC v8 | IVC 期结直肠癌 AJCC v8 | III 期结直肠癌 AJCC v8 | IIIA 期结直肠癌 AJCC v8 | IIIB 期结直肠癌 AJCC v8 | IIIC 期结直肠癌 AJCC v8 | BRAF V600E 负极 | KRAS基因突变阴性 | 局部晚期不可切除结直肠腺癌 | NRAS基因突变阴性美国
-
Regeneron Pharmaceuticals招聘中继发于 Otoferlin 基因 (OTOF) 双等位基因突变的先天性听力损失西班牙, 英国, 美国
-
Blueprint Medicines Corporation主动,不招人肿瘤 | 组织学类型的肿瘤 | 肺部疾病 | 按部位分类的肿瘤 | 腺癌 | 癌 | 癌,非小细胞肺癌 | 肺肿瘤 | 呼吸道肿瘤 | 胸部肿瘤 | 癌,支气管癌 | 支气管肿瘤 | 肿瘤,神经组织 | EGF-R阳性非小细胞肺癌 | 抗肿瘤药 | EGFR激活突变 | 呼吸道疾病 | 表皮生长因子受体基因突变 | EGFR C797S | EGFR L858R | EGFR 外显子 19 缺失 | EGFR突变导致酪氨酸激酶抑制剂耐药 | 蛋白激酶抑制剂 | EGFR T790M美国, 加拿大, 台湾, 大韩民国, 新加坡, 日本, 英国, 法国, 荷兰, 西班牙
-
Wake Forest University Health SciencesNational Center for Complementary and Integrative Health (NCCIH); University of Arizona; Office...完全的
-
The Netherlands Cancer InstituteDaiichi Sankyo, Inc.尚未招聘表皮生长因子受体基因突变 | 非小细胞肺癌 | 晚期非小细胞鳞状肺癌
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest Hospital未知化疗效果 | KRAS基因突变 | NSCLC IV期 | PD-1抗体
-
Shanghai Pulmonary Hospital, Shanghai, China招聘中
-
Boston Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National... 和其他合作者完全的
-
Harvard School of Public Health (HSPH)完全的Gene and Diet Interaction
-
Sun Yat-sen University招聘中
-
Dr Joanne CHIU招聘中ALK基因重排阳性 | EGF-R阳性非小细胞肺癌 | EGFR激活突变 | NSCLC | ROS1基因重排 | ROS1 阳性 NSCLC - 活性氧 1 阳性非小细胞肺癌香港
-
PfizerFrench College of General Hospital Pneumologists (CPHG)完全的
-
Children's Healthcare of AtlantaEmory University; Brigham and Women's Hospital; University of California, San Francisco; University... 和其他合作者撤销
-
University Hospital, GhentFox Chase Cancer Center; Ziekenhuis Oost-Limburg完全的
-
Ohio State University Comprehensive Cancer CenterImmunoGen, Inc.; Clovis Oncology, Inc.主动,不招人BRCA1基因突变 | BRCA2基因突变 | 叶酸受体α阳性 | 复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 复发性子宫体癌 | 复发性子宫浆液性癌 | 复发性子宫癌肉瘤 | 铂耐药卵巢癌美国
-
National Cancer Institute (NCI)完全的治疗相关的急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | FLT3基因突变 | 伴有 PML-RARA 的急性早幼粒细胞白血病 | 具有 Inv(16)(p13.1q22) 或 t(16;16)(p13.1;q22) 的急性髓性白血病; CBFB-MYH11 | 急性髓性白血病伴 t(8;21); (q22; q22.1); RUNX1-RUNX1T1美国
-
Alpha Biopharma (Jiangsu) Co., Ltd.完全的
-
Scripps HealthJ. Craig Venter Institute完全的
-
National Human Genome Research Institute (NHGRI)National Center for Advancing Translational Sciences (NCATS)完全的
-
Daping Hospital and the Research Institute of Surgery...尚未招聘非小细胞肺癌 | 表皮生长因子受体基因突变
-
Karolinska University HospitalSahlgrenska University Hospital, Sweden招聘中
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Baylor College of Medicine; City of Hope Medical Center招聘中
-
Nanjing First Hospital, Nanjing Medical University完全的
-
Zhejiang Cancer Hospital主动,不招人
-
Swiss Group for Clinical Cancer Research完全的